Cerebral oxidative stress is frequently observed in patients with OHE, and hyperammonemia plays an important role in its development [60, 61]
Switch to Subscription
GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda), as well as the dual GIP/GLP-1 receptor agonist tirzepatide (Mounjaro, Zepbound), may contribute to this uncomfortable symptom through their effects on digestion
Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits are now being pursued against the manufacturers of these weight loss and diabetes drugs, claiming the companies failed to adequately research the potential gastroparesis side effects or warn that users may experience
Growth hormone replacement in healthy older men improves body composition but not functional ability